DOP079: Predictors of first neoplastic colonic lesion in patients with inflammatory bowel disease undergoing colonoscopic surveillance

DOP080: iNKT cells contribute to Ulcerative Colitis through a Th1/Th17 immune response

DOP080: Final results of a randomized study comparing high definition colonoscopy alone with high definition dye spraying and electronic virtual chromoendoscopy using iSCAN for detection of colonic neoplastic lesions during IBD surveillance colonoscopy.

DOP081: Soft ROCK inhibition prevents intestinal fibrosis in a murine colitis mode

DOP081: Outcomes of Colitis-Associated Dysplasia after Referral from the Community to a Tertiary Center

DOP082: Genome-wide association identifies multiple collagenous colitis susceptibility loci

DOP082: PEA immunoassay technology identifies novel serum biomarkers that can diagnose and classify Inflammatory Bowel Diseases: IBD Character Consortium

DOP083: Comparison of disease phenotype in 35,128 European and 4,686 non-European IBD cohort of the IIBDGC

DOP083: Fecal calprotectin improves the predictive power of 3 practical indices for mucosal healing among patients with Crohn’s disease: results from PREDICT

DOP084: Interpreting genetic variants in IBD as quantitative immune traits by the assessment of cytokine profiles

DOP084: Identification of a potential new prognostic biomarker to select IBD patients that fail standard therapy

DOP085: A candidate gene study of rare monogenic disorders with IBD-like phenotype identified rare variants in XIAP gene in a cohort of early-onset IBD patients

DOP085: Ileocolonic Involvement and Diagnosis is Related to Fragments of the Extracellular Matrix Measured in Serum of Patients with Crohn’s Disease.

DOP086: Enteric micriobiota alterations in patients with a normal ileal pouch may be predictive of pouchitis

DOP086: Fecal chitinase 3-like 1 is a reliable marker as accurate as fecal calprotectin in detecting endoscopic activity in adult patients with inflammatory bowel diseases

DOP087: Intestinal microbial signature in patients with primary sclerosing cholangitis

DOP088: Inflammatory biomarkers in serum discriminate Crohn’s disease and ulcerative colitis from healthy controls

DOP089: Microbiota profiles in treatment naïve Norwegian IBD and non-IBD patients. Part of the EU IBD character consortium

DOP090: Dysbiosis of oral microbiome in adult Chinese patients with active Inflammatory Bowel Diseases

DOP090: The Role of The Microbiome in Clinical Response to Golimumab in Ulcerative Colitis